Addex Therapeutics
Price & Volume
Stats
See moreOpen | $5.78 |
Previous Close | $6.45 |
Day Range | $5.78-$5.78 |
52W Range | $5.41-$12.04 |
Market Cap | $8.2M |
Shares Short | 4,982 |
Financials
See moreRevenue (12 Mos) | $172,860 |
Revenue Growth (YoY) | 949.7% |
Gross Profit (12 Mos) | -$498,791 |
Diluted EPS | -$8.92 |
News
See moreYahoo Finance • 3 days ago
Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026
Yahoo Finance • 20 days ago
Addex Convenes Annual General Meeting 2026
Yahoo Finance • 2 months ago
Addex Reports Neurosterix On Track To Complete Phase 1 Trial For Schizophrenia Drug NTX-253
Yahoo Finance • 2 months ago
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model
About
CEO | Mr. Timothy Mark Dyer |
Address | Chemin des Mines, 9, Geneva, Switzerland, 1202 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3 |